Jw Life Science Corp (234080) fair value: what the stock is really worth
As of Nov 19, 2026: fair value (intrinsic value) of Jw Life Science Corp stock KRW 30,641, price KRW 10,660, upside +187.4%, quality 61 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Jw Life Science Corp
234080 · KOCheap (65% below fair value) and solid company, but falling price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range 9,444 KRW – 16,021 KRW · fair‑value band 19,221 KRW – 39,833 KRW · the 10,660 KRW price screens below the 30,641 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Jw Life Science is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
JW Lifescience Corporation provides national infusion solutions in South Korea and internationally.
Show moreShow less
The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions.
The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea.
Stock analysis
Jw Life Science Corp (234080) currently trades at 10,660 KRW, while our model-based Fair Value estimate is 30,641 KRW, implying the stock looks roughly 65% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 32,642 KRW per share, and 23 of the 26 models we run sit above the 10,660 KRW price.
Bear case: the Asset-Based group reads lowest at 6,209 KRW, and 3 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: 19,221 KRW (bear) to 39,833 KRW (bull), the price of 10,660 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 61/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Jw Life Science Corp reported revenue of 258B KRW in FY2025 versus 170B KRW in FY2021, a compound +11.0%/yr. Reported net income was 28.6B KRW in FY2025, compounding +22.0%/yr from FY2021.
Key figures
Market cap 165B KRW (≈ $124M) Micro · P/E ratio 6.3 · P/S ratio 0.65 · EPS (TTM) 1,680 KRW · Dividend yield 5.2% · Net margin 10.3% · Return on equity 11.9% · Return on assets (EBIT) 11.4% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).
What moves the price
The share trades about 27% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at 187%, 234080 screens cheaper than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch 234080, get fair value alerts →
Compare Jw Life Science Corp with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 608 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: South Korean Stocks
- Valuation of the Korea market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $85.57 | $113.53 | +33% | vs 234080 |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥46.88 | ¥52.43 | +12% | vs 234080 |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,900 | ₹1,983 | +4% | vs 234080 |
| Haleon plc HLN | $9.08 | $8.47 | −7% | vs 234080 |
| Merck KGaA MRK | €148.40 | €108.83 | −27% | vs 234080 |
| Galderma Group GALD | CHF 184.70 | CHF 112.46 | −39% | vs 234080 |
| Takeda Pharmaceutical Company TAK | $21.27 | $11.23 | −47% | vs 234080 |
| Sandoz Group SDZ | CHF 81.24 | CHF 41.06 | −49% | vs 234080 |
| Teva Pharmaceutical Industries Limited TEVA | $42.23 | $20.74 | −51% | vs 234080 |
| Divi's Laboratories Limited DIVISLAB | ₹11,178 | ₹1,567 | −86% | vs 234080 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Jw Life Science Corp (234080) overvalued or undervalued?
What is the fair value of 234080?
What is the quality score of 234080?
What is the price target for Jw Life Science Corp (234080)?
What is the Jw Life Science Corp stock forecast for 2026?
What is the revenue of Jw Life Science Corp (234080)?
Does Jw Life Science Corp pay a dividend?
How much is the dividend of Jw Life Science Corp (234080) and when is the ex-dividend date?
What growth is priced into Jw Life Science Corp (234080)?
What discount rate (WACC) does the fair value of 234080 use?
What is a reverse DCF?
How much growth has Jw Life Science Corp (234080) delivered so far?
How fast is the sector of Jw Life Science Corp (234080) growing?
What is the free cash flow yield of Jw Life Science Corp (234080)?
What is the intrinsic value of Jw Life Science Corp (234080)?
Is Jw Life Science Corp stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 234080?
How much is Jw Life Science Corp worth?
What do the bullish and bearish scenarios say about 234080?
What is the P/E ratio of 234080?
How solid is the balance sheet of Jw Life Science Corp (234080)?
How far is 234080 from its 52-week high?
Which stocks are comparable to Jw Life Science Corp?
Is Jw Life Science Corp stock attractive at the current price?
How is the fair value of 234080 calculated?
Is it still worth investing in stocks now?
What is the share price of Jw Life Science Corp (234080)?
What should I pay attention to with Jw Life Science Corp right now?
Key figures of Jw Life Science Corp
How large is the market capitalisation of Jw Life Science Corp (234080)?
What is the P/S ratio of Jw Life Science Corp (234080)?
What are the earnings per share of Jw Life Science Corp (234080)?
What is the dividend yield of Jw Life Science Corp (234080)?
What is the net margin of Jw Life Science Corp (234080)?
What is the return on equity of Jw Life Science Corp (234080)?
What is the EBIT return on assets of Jw Life Science Corp (234080)?
What is the operating margin of Jw Life Science Corp (234080)?
How fast is revenue growing at Jw Life Science Corp (234080)?
How fast are earnings growing at Jw Life Science Corp (234080)?
How much net debt does Jw Life Science Corp (234080) carry?
Watch Jw Life Science Corp in the live analysis
One click puts Jw Life Science Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.